National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$49.00
add to cart

Rights & Permissions

topleft topright

Issues in Risk Assessment (1993)
Commission on Life Sciences (CLS)

Citation Manager

. "CONSISTENCY OF CASE STUDIES WITH THE 1983 FRAMEWORK." Issues in Risk Assessment. Washington, DC: The National Academies Press, 1993.

Please select a format:

BibTeX EndNote RefMan


Page
251
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Issues in Risk Assessment

as "the process of estimating the incidence of a health effect under the various conditions of human exposure described in exposure assessment. It is performed by combining the exposure and dose-response assessments. The summary of effects of the uncertainties in the preceding steps are described in this step."

The 1983 report further defined points in the risk assessment process ("components") where inferences must be made and scientifically plausible options ("inference options") from which a risk assessor must choose regarding those components. The report did not, however, include in-depth discussion of scientific issues in health risk assessment. The 1983 committee's objectives were limited to addressing institutional and procedural issues: whether the analytic process of risk assessment should be cleanly separated from the regulatory process of risk management, whether a single organization could be designated to perform risk assessments for all regulatory agencies, and whether uniform risk assessment guidelines could be developed for use by all regulatory agencies. The general framework for health risk assessment developed by the 1983 committee (Figure 3-1) was intended to define the boundaries between risk assessment and risk management and to facilitate the development of uniform technical guidelines. The committee recommended that a board on risk assessment methods be established and assigned the tasks of assessing the scientific basis of risk assessment, establishing inference guidelines, evaluating agency experiences with risk assessment, and identifying research needs in risk assessment.

CONSISTENCY OF CASE STUDIES WITH THE 1983 FRAMEWORK

Most of the case studies fit reasonably well into the 1983 framework, although the relative emphasis on the four components of risk assessment varied considerably among the studies. The three case studies dealing with environmental chemicals provided the most obvious fits. All three included discussions of hazard identification, defined as determination of the physical, chemical, and toxic effects of the substances or stresses being examined. They differed substantially in their balance between data and models, but a fairly clean distinction could be drawn between exposure assessment (patterns of contamination in time and

Page
251
Front Matter (R1-R18)
Executive Summary (1-2)
USE OF THE MAXIMUM TOLERATED DOSE IN ANIMAL BIOASSAYS FOR CARCINOGENICITY (3-8)
THE TWO-STAGE MODEL OF CARCINOGENESIS (9-9)
A PARADIGM FOR ECOLOGIC RISK ASSESSMENT (10-12)
Issues In Risk Assessment Use Of Maximum Tolerated Dose in Animal Bioassays for Carcinogenicity (13-14)
BACKGROUND (15-17)
SCOPE OF REPORT (18-20)
DEFINITIONS AND BACKGROUND (21-23)
CORRELATIONS (24-32)
RELATIONSHIP BETWEEN TOXICITY AND CARCINOGENICITY OBSERVED AT MTD (33-42)
QUALITATIVE INFORMATION (43-48)
QUANTITATIVE INFORMATION (49-52)
OPTION 1 (53-53)
OPTION 2 (54-54)
OPTION 3 (55-56)
Option 4A (57-58)
Option 4B (59-60)
5 Conclusions and Recommendations (61-66)
REFERENCES (67-78)
BACKGROUND (79-79)
DEFINING AND DETERMINING THE MTD (80-90)
Appendix B Organizing Subcommittee (91-92)
Appendix C Federal Liaison Group (93-94)
Appendix D Workshop Program (95-96)
Appendix E Workshop Attendees (97-110)
1. INTRODUCTION (111-112)
2.1 Measures of Carcinogenic Potency (113-115)
2.2 Carcinogenic Potency Database (CPDB) (116-116)
2.3 Variation in Carcinogen Potency (117-118)
2.4 Classification of Carcinogens (119-120)
3.1 Empirical Correlations (121-124)
3.2 Range of Possible TD50 Values (125-125)
3.3 Analytical Correlations (126-127)
3.4 Model Dependency (128-129)
3.5 Genotoxic vs. Nongenotoxic Carcinogens (130-130)
4.1 Predictions Based on the MDT (131-131)
4.2 Predictions Based on Mutagenicity and Acute Toxicity (132-134)
5.1 Correlation Between Upper Bounds On the Low Dose Slope and MTD (135-135)
5.2 Correlation Between q1* and the TD50 (136-138)
5.3. Preliminary Estimate of Risk (139-139)
6. INTERSPECIES EXTRAPOLATION (140-140)
6.1 Extrapolation from Rats to Mice (141-143)
6.2 Extrapolation from Rodents to Humans (144-145)
7. CONCLUSIONS (146-148)
8. ACKNOWLEDGEMENTS (149-149)
9. REFERENCES (150-159)
ANNEX A: MAXIMUM LIKELIHOOD METHODS FOR FITTING THE WEIBULL MODEL (160-161)
ANNEX B. SHRINKAGE ESTIMATORS OF THE DISTRIBUTION OF CARCINOGENIC POTENCY (162-163)
ANNEX C: ADJUSTMENT OF POTENCY VALUES FOR LESS THAN LIFETIME EXPOSURE (164-165)
ANNEX D: CORRELATION BETWEEN TD50 AND MTD (166-168)
ANNEX E: CORRELATION BETWEEN TD50S FOR RATS AND MICE (169-172)
Appendix G Informal Search for ''Supercarcinogens" (173-174)
CRITERIA AND CANDIDATE CHEMICALS (175-176)
DATA (177-180)
RESULTS (181-181)
DISCUSSION (182-184)
Issues in Risk Assessment The Two-Stage Model Of Carcinogenesis (185-186)
INTRODUCTION (187-187)
BIOLOGIC CONSIDERATIONS (188-189)
THE TWO-STAGE MODEL (190-195)
APPLICATIONS OF THE TWO-STAGE MODEL TO ANIMAL DATA (196-211)
Data Needs (212-212)
Criteria for Adoption (213-213)
Prospects (214-214)
CONCLUSIONS AND RECOMMENDATIONS (215-216)
REFERENCES (217-222)
BIOLOGICAL FACTORS IN TWO-STAGE MODELS (223-225)
TWO-STAGE MODEL OF CLONAL EXPANSION (226-227)
APPLICATION OF THE TWO-STAGE MODEL TO ANIMAL DATA (228-232)
Appendix B Workshop Program (233-234)
Appendix C Workshop Federal Liaison Group (235-236)
TOPIC GROUP MEMBERS (237-238)
Appendix E Workshop Organizing Task Group (239-240)
Isuees In Risk Assessment A Paradigm for Ecological Risk Assessment (241-242)
1 Introduction (243-246)
2 Scope of Ecological Risk Assessment (247-248)
COMPONENTS OF THE 1983 FRAMEWORK (249-250)
CONSISTENCY OF CASE STUDIES WITH THE 1983 FRAMEWORK (251-253)
INTEGRATION OF ECOLOGICAL RISK INTO THE 1983 FRAMEWORK (254-254)
DEFINITION OF FRAMEWORK COMPONENTS FOR ECOLOGICAL RISK ASSESSMENT (255-258)
EXTRAPOLATION ACROSS SCALES (259-260)
QUANTIFICATION OF UNCERTAINTY (261-261)
VALIDATION OF PREDICTIVE TOOLS (262-262)
VALUATION (263-264)
5 Conclusions (265-266)
6 Recommendations (267-268)
REFERENCES (269-272)
Appendix A Workshop Participants (273-278)
Appendix B Workshop Organizing Subcommittee and Federal Liaison Group (279-280)
Appendix C Workshop Introduction (281-282)
TERRY F. YOSIE BUILDING ECOLOGICAL RISK ASSESSMENT AS A POLICY TOOL (283-285)
D. WARNER NORTH: RELATIONSHIP OF WORKSHOP TO NRC'S 1983 RED BOOK REPORT (286-288)
MICHAEL SLIMAK: U.S. ENVIRONMENTAL PROTECTION AGENCY ACTIVITIES IN ECOLOGICAL RISK ASSESSMENT (289-292)
CASE STUDY 1: TRIBUTYLTIN RISK MANAGEMENT IN THE UNITED STATES (293-293)
Discussion (294-294)
CASE STUDY 2: ECOLOGICAL RISK ASSESSMENT FOR TERRESTRIAL WILDLIFE EXPOSED TO AGRICULTURAL CHEMICALS (295-296)
CASE STUDY 3A: MODELS OF TOXIC CHEMICALS IN THE GREAT LAKES: STRUCTURE, APPLICATIONS, AND UNCERTAINTY ANALYSIS (297-298)
CASE STUDY 3B: ECOLOGICAL RISK ASSESSMENT OF TCDD AND TCDF (299-299)
Discussion (300-300)
CASE STUDY 4: RISK ASSESSMENT METHODS IN ANIMAL POPULATIONS: THE NORTHERN SPOTTED OWL AS AN EXAMPLE (301-301)
Discussion (302-302)
CASE STUDY 5: ECOLOGICAL BENEFITS AND RISKS ASSOCIATED WITH THE INTRODUCTION OF EXOTIC SPECIES FOR BIOLOGICAL CONTROL OF A... (303-303)
Discussion (304-304)
CASE STUDY 1: UNCERTAINTY AND RISK IN AN EXPLOITED ECOSYSTEM: A CASE STUDY OF GEORGES BANK (305-306)
Discussion (307-308)
Generic Issues (309-309)
Analysis of Case Studies (310-310)
DOSE-RESPONSE ASSESSMENT (311-311)
Selection of End Points (312-312)
Consideration of Nonlinearities And Discontinuities (313-313)
Understanding the Stressor (314-314)
Additions to the 1983 Paradigm Needed for Ecological Risk Assessment (315-315)
Modeling Needs for Stress-Response Relationships (316-316)
Methods of Measuring Stressors for Ecological Exposure Assessment (317-317)
Definition of Risk Characterization (318-318)
Components of Risk Characterization (319-319)
Organization and Presentation (320-320)
Differences from and Similarities To the 1983 Report (321-321)
Application to the Case Studies (322-323)
Agricultural Chemicals (324-324)
Northern Spotted Owl (325-325)
General Discussion: Models and Risk Assessment (326-326)
Uncertainties Identified In the Case Studies (327-327)
Implications of Uncertainty for Ecological Risk Assessment (328-328)
VALUATION (329-330)
Risk Assessment Has Many Uses (331-332)
Different Risk Assessment Methods Are Suited to Different Risk Assessment Needs (333-333)
Risk Assessors and Risk Managers Need to Communicate (334-334)
Credibility is Crucial (335-336)
Appendix G Contemplations on Ecological Risk Assessment (337-342)
Appendix H Workshop Summary (343-346)
Appendix I References for Appendixes (347-350)
Appendix J Workshop Program (351-356)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 251
Issues in Risk Assessment as "the process of estimating the incidence of a health effect under the various conditions of human exposure described in exposure assessment. It is performed by combining the exposure and dose-response assessments. The summary of effects of the uncertainties in the preceding steps are described in this step." The 1983 report further defined points in the risk assessment process ("components") where inferences must be made and scientifically plausible options ("inference options") from which a risk assessor must choose regarding those components. The report did not, however, include in-depth discussion of scientific issues in health risk assessment. The 1983 committee's objectives were limited to addressing institutional and procedural issues: whether the analytic process of risk assessment should be cleanly separated from the regulatory process of risk management, whether a single organization could be designated to perform risk assessments for all regulatory agencies, and whether uniform risk assessment guidelines could be developed for use by all regulatory agencies. The general framework for health risk assessment developed by the 1983 committee (Figure 3-1) was intended to define the boundaries between risk assessment and risk management and to facilitate the development of uniform technical guidelines. The committee recommended that a board on risk assessment methods be established and assigned the tasks of assessing the scientific basis of risk assessment, establishing inference guidelines, evaluating agency experiences with risk assessment, and identifying research needs in risk assessment. CONSISTENCY OF CASE STUDIES WITH THE 1983 FRAMEWORK Most of the case studies fit reasonably well into the 1983 framework, although the relative emphasis on the four components of risk assessment varied considerably among the studies. The three case studies dealing with environmental chemicals provided the most obvious fits. All three included discussions of hazard identification, defined as determination of the physical, chemical, and toxic effects of the substances or stresses being examined. They differed substantially in their balance between data and models, but a fairly clean distinction could be drawn between exposure assessment (patterns of contamination in time and

OCR for page 252
Issues in Risk Assessment space, exposure, and doses) and dose-response assessment (quantitative relation of exposures to toxic effects). The Georges Bank study appeared to be the most complete of the six. The determination of the qualitative effects of fishing on population and community dynamics is clearly analogous to the determination of contaminant effects and can legitimately be called "hazard identification." Estimates of fishing effort and models of the responses of populations to exploitation are equivalent to exposure and dose-response assessment of chemicals. The expression of outcomes in terms of likely future population sizes and yields carries risk characterization several steps further than was done in any of the contaminant studies. The spotted owl study focused on only one aspect of the assessment process: estimation of basic demographic characteristics of spotted owl populations. However, other published work on the spotted owl (Dawson et al., 1986; Salwasser, 1986) available to the committee relates forest-cutting patterns to population dynamics and clearly includes exposure and dose-response assessments in the sense in which these terms are used in the Red Book framework. The species introduction case study does not appear at first to fit the standard definition of a risk assessment. No scientific principles or decision criteria were presented at the workshop, although theoretical work was described in some of the breakout sessions. The consensus among participants in the workshop was that the procedure used by the U.S. Department of Agriculture (USDA) to evaluate proposed species introductions is not risk assessment. The committee believes, however, that USDA's process fits within the general definition of hazard identification as presented in the 1983 report. The objective appears to be to collect enough information to determine whether a proposed introduction constitutes a hazard to the environment. If no hazard is found, the introduction proceeds. The USDA process might more accurately be described as safety assurance. One weakness in all the case studies was inadequate risk characterization. Only one of the case studies, the Georges Bank study, included any quantification of risks in terms that could be used for risk-benefit calculations, valuation studies, or other quantitative comparisons applicable to decision-making. Even in this case, the value of the assessment to decision-making is uncertain. During the plenary discussion, the author of the study emphasized that communication between scientists

OCR for page 253
Issues in Risk Assessment and managers is still inadequate and that fisheries management actions are often only marginally influenced by quantitative assessments. The committee notes that risk characterization is the least-developed component of the 1983 framework. In the 1983 report, risk characterization is defined simply as an integration of exposure and dose-response information. It seems clear from the 1991 workshop that effective ecological risk characterization is more than an exercise in arithmetic. Many of the results presented at the workshop have no immediate relevance to decision-making and mean little or nothing to the public. The procedure used in pesticide registration, as described in the agricultural chemical case study, provides an excellent example. The method used is to compare doses that cause death or impairment of standard test birds with estimated exposures in typical applications. On the basis of the comparison, the risk manager is expected to make a decision about the environmental acceptability of the pesticide being considered. No attempt is made to account for interspecies differences, to assess the threat to the viability of wild avian populations, to estimate the fraction of the landscape that might be affected, or to quantify the value of the wildlife that might be lost. Ecological risk assessments have no equivalent of the lifetime cancer risk estimate used in health risk assessment. The ecological risks of interest differ qualitatively between different stresses, ecosystem types, and locations. The value of avoiding these risks is not nearly as obvious to the general public as is the value of avoiding exposure to carcinogens. Because few risk managers are trained as ecologists, effective communication between risk managers and technical staff is essential in sound risk management decisions. Approaches to hazard identification exemplified in the case studies were, on the other hand, substantially more diverse and in some cases more sophisticated than envisioned in the 1983 framework. The 1983 definition of this component was limited to scientific inferences about whether specific effects, such as cancer, were causally associated with specific chemical substances. Identification of ecological hazards also includes identification of specific species or ecosystems of interest, delineation of study areas, and determination of types of laboratory or field data on which an assessment will be based. These decisions reflect both scientific considerations (which systems are vulnerable? what kinds of effects are possible?) and management considerations (which species